<DOC>
	<DOC>NCT01072201</DOC>
	<brief_summary>Clinical research for the treatment of mucositis subjects who have dental implants for a minimum of one-year.</brief_summary>
	<brief_title>To Access the Effects of Mucositis in Adults With Dental Implants</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Triclosan</mesh_term>
	<criteria>Male and female subjects, ages 3070. Availability for the sixmonth duration of the clinical research study. Good general health. Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants. Minimum of 5 remaining teeth and a minimum of 2 implants. Initial evaluation of the gingival and periimplant mucosal tissues by determining full mouth bleeding on probing. Initial plaque evaluation by determining full mouth presence/absence of plaque. Signed Informed Consent Form. Tumor(s) of the soft or hard tissues of the oral cavity. Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone). Carious lesions requiring immediate restorative treatment. Uncontrolled Diabetes Use of antibiotics any time during the one month prior to entry into the study. Untreated periimplantitis. Participation in any other clinical research study or test panel within the three months prior to entry into the study. Pregnant women or women who are breast feeding. History of allergies to personal care/consumer products or their ingredients. Medical condition which prohibits not eating/drinking for up to 2 hours. Current alcohol or drug abuse. Systemic or local disease conditions that would compromise postoperative healing. Regular use of antiinflammatory drugs.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>